Real time Form 13D and 13G transaction reports:

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Type Company
Symbol
Filed By
Symbol
Shares Owned Percent Owned Vs. Prev Report Filing
2019-06-04
4:52 pm
Sale
13D Orexigen Therapeutics, Inc.
OREX
BAUPOST GROUP LLC/MA 0 0% -11,332,219decrease
(Position Closed)
View
2019-02-14
5:20 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
BIOTECHNOLOGY VALUE FUND L P 1,687,702 8.3% 628,660increase
(+59.36%)
View
2019-02-14
3:51 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
Telemetry Investments, L.L.C. 1,295,844 6.4% 40,783increase
(+3.25%)
View
2019-02-12
3:36 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
UBS OCONNOR LLC 2,096,227 9.99% 16,419increase
(+0.79%)
View
2019-02-12
3:05 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
Nineteen77 Global Multi-Strategy Alpha Master Ltd 2,096,227 9.99% 16,419increase
(+0.79%)
View
2019-02-11
2:29 pm
Sale
13G Orexigen Therapeutics, Inc.
OREX
Man Group plc 0 0% -1,524,143decrease
(Position Closed)
View
2018-10-31
4:00 pm
Purchase
13D Orexigen Therapeutics, Inc.
OREX
BAUPOST GROUP LLC/MA 11,332,219 37.5% 927,803increase
(+8.92%)
View
2018-10-26
4:10 pm
Purchase
13D Orexigen Therapeutics, Inc.
OREX
BAUPOST GROUP LLC/MA 10,404,416 37.5% 408,300increase
(+4.08%)
View
2018-04-26
4:49 pm
Purchase
13D Orexigen Therapeutics, Inc.
OREX
BAUPOST GROUP LLC/MA 9,996,116 37.5% 2,598,151increase
(+35.12%)
View
2018-02-14
12:07 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
Telemetry Investments, L.L.C. 1,255,061 6.3% 20,722increase
(+1.68%)
View
2018-02-13
1:55 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
UBS OCONNOR LLC 2,079,808 9.99% 2,079,808increase
(New Position)
View
2018-02-13
12:18 pm
Sale
13G Orexigen Therapeutics, Inc.
OREX
Foresite Capital Fund II, L.P. 0 0% -174,373decrease
(Position Closed)
View
2018-02-12
12:27 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
Nineteen77 Global Multi-Strategy Alpha Master Ltd 2,079,808 9.99% 2,079,808increase
(New Position)
View
2018-02-09
11:14 am
Sale
13G Orexigen Therapeutics, Inc.
OREX
Man Group plc 1,524,143 8.13% -75,857decrease
(-4.74%)
View
2017-12-01
12:03 pm
Purchase
13G Orexigen Therapeutics, Inc.
OREX
Man Group plc 1,600,000 8.54% 1,600,000increase
(New Position)
View